SCHEMBL9562326

SCHEMBL9562326

O=C1CCc2cc(C(O)CN3CCC(C(=O)Cc4ccc(F)cc4)CC3)ccc2N1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.56
GRIN2B Q13224 3/20 0.50
TSHR P16473 2/20 0.42
GMNN O75496 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
NFKB1 P19838 1/20 0.42
THPO P40225 1/20 0.42
MTOR P42345 1/20 0.42
BLM P54132 1/20 0.42
GRIN1 Q05586 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 3/20 0.40
METAP2 P50579 3/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
HTR1A P08908 1/20 0.40
DRD2 P14416 1/20 0.40
HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9562529 0.84 KCNH2 (0.57) KCNH2GRIN2BTSHRGMNNTP53
SCHEMBL9768325 0.84 KCNH2 (0.61) KCNH2GRIN2BTSHRGMNNTP53
SCHEMBL9562497 0.79 KCNH2 (0.57) KCNH2GRIN2BTSHRGMNNTP53
SCHEMBL9562306 0.79 KCNH2 (0.57) KCNH2GRIN2BTSHRGMNNTP53
SCHEMBL9768368 0.77 GRIN2B (0.60) KCNH2GRIN2BTSHRGMNNTP53
SCHEMBL9561877 0.76 KCNH2 (0.52) KCNH2GRIN2BTSHRALDH1A1GAA
SCHEMBL9562489 0.75 KCNH2 (0.51) KCNH2GRIN2BTSHRGMNNTP53
SCHEMBL466863 0.75 GRIN2B (0.61) KCNH2GRIN2BALDH1A1HTR1ADRD2
SCHEMBL8439768 0.74 KCNH2 (0.54) KCNH2GRIN2BTSHRALDH1A1GAA
SCHEMBL9561851 0.74 GRIN2B (0.56) KCNH2GRIN2BTSHRALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0524846-A1 2-(Piperidin-1-yl)ethanol derivatives, their preparation and their use in therapeutics SYNTHELABO (FR) 1993-01-27 EP disclosed